Clearstead Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40 Hold
4
﹤0.01% 3511
2026
Q1
$39 Sell
4
-6
-60% -$55 ﹤0.01% 2215
2025
Q4
$96 Sell
10
-11
-52% -$112 ﹤0.01% 2522
2025
Q3
$205 Buy
21
+17
+425% +$131 ﹤0.01% 2857
2025
Q2
$25 Hold
4
﹤0.01% 2697
2025
Q1
$50 Hold
4
﹤0.01% 2161
2024
Q4
$56 Hold
4
﹤0.01% 2063
2024
Q3
$67 Hold
4
﹤0.01% 2004
2024
Q2
$83 Buy
+4
New +$87 ﹤0.01% 1991

Other funds holding PRTA

Clearstead Advisors's PRTA Position: Q2 2026 in Review

Clearstead Advisors held its Prothena Corp (PRTA) position steady in Q2 2026 at 4 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Clearstead Advisors first reported a position in PRTA in Q2 2024 and has held it in 9 quarters since. The position peaked at $205 in Q3 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Clearstead Advisors held 4 shares of Prothena Corp worth $40 as of Q2 2026.
  • Clearstead Advisors left its Prothena Corp share count unchanged in Q2 2026.
  • Prothena Corp made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3511 holding.
  • Clearstead Advisors first reported a position in Prothena Corp in Q2 2024 and has held it in 9 quarters since.
  • Clearstead Advisors's Prothena Corp position peaked at $205 in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.